Carregant...
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
OBJECTIVE: To report our experiences in changing from intravitreal bevacizumab to ranibizumab in age-related macular degeneration (AMD). DESIGN: Retrospective case series. PARTICIPANTS AND METHODS: We retrospectively reviewed the records of 34 patients (36 eyes) who were treated with monthly injecti...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2801585/ https://ncbi.nlm.nih.gov/pubmed/20054410 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|